Bradykinin (2-9) is an amino-truncated Bradykinin peptide. Bradykinin (2-9) is a metabolite of Bradykinin, cleaved by Aminopeptidase P.
Bradykinin 2-9 is a synthetic peptide fragment derived from the nonapeptide bradykinin, specifically comprising the amino acid sequence from the second to the ninth residue. As a truncated form of the endogenous vasoactive peptide, it retains key structural motifs responsible for receptor interaction and biological activity, making it a valuable tool in peptide research. Due to its defined sequence and biochemical properties, this fragment is widely utilized in studies investigating the structure-activity relationships of kinins, receptor binding specificity, and enzymatic degradation pathways. Its relevance spans molecular pharmacology, receptor biology, and enzymology, supporting advanced research into the physiological and pathophysiological roles of bradykinin and related peptides.
Receptor binding studies: Bradykinin 2-9 serves as an important probe in the elucidation of bradykinin receptor interactions, particularly with B2 and B1 receptor subtypes. By analyzing the binding affinities and activity profiles of this peptide fragment compared to the full-length bradykinin, researchers can identify critical sequence determinants for receptor activation or inhibition. Such investigations provide insights into the molecular basis of kinin-receptor selectivity, facilitating the development of novel receptor modulators and advancing understanding of signal transduction mechanisms in vascular and inflammatory systems.
Structure-activity relationship analysis: The defined sequence of this peptide fragment enables detailed examination of the structural features that govern biological activity within the kinin family. By systematically comparing truncated and modified analogs, scientists can map the functional domains necessary for receptor engagement, enzymatic cleavage, or downstream signaling. These studies are instrumental in designing optimized kinin analogs with tailored pharmacological profiles, supporting both basic research and preclinical discovery efforts.
Enzymatic degradation research: As a substrate or inhibitor in enzymatic assays, the peptide fragment is frequently employed to investigate the specificity and kinetics of kinin-degrading enzymes such as kininases and angiotensin-converting enzyme (ACE). Its use allows for the dissection of proteolytic pathways that regulate bradykinin bioavailability and activity in physiological fluids. Such research is crucial for understanding the metabolic fate of kinins, the modulation of inflammatory responses, and the interplay between peptide signaling and enzymatic control.
Peptide synthesis and analytical method development: The availability of this well-characterized peptide fragment supports the calibration and validation of analytical techniques, including high-performance liquid chromatography (HPLC) and mass spectrometry, that are essential for peptide quantification and purity assessment. It also serves as a reference standard in synthetic peptide production workflows, enabling optimization of solid-phase synthesis protocols and quality control procedures. These applications are vital for ensuring reproducibility and reliability in peptide-based research and development.
Pharmacological assay development: Researchers frequently incorporate this peptide fragment into in vitro and ex vivo assay systems to model bradykinin-mediated responses, assess antagonist or agonist activity, and screen for modulators of kinin signaling. Its defined structure and bioactivity facilitate the establishment of robust, reproducible assays for drug discovery, mechanistic studies, and functional characterization of receptor-ligand interactions. By providing a consistent and biologically relevant tool, the fragment enhances the precision and interpretability of pharmacological investigations within the kinin system.
4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More